This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nexbiome Therapeutics. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Claudia Thoral: Innovator in Mucoadhesive Drug Delivery Systems
Introduction
Claudia Thoral is a prominent inventor based in Massiac, France. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. Her work focuses on enhancing the efficacy and usability of medications through advanced formulations.
Latest Patents
Claudia Thoral holds a patent for a mucoadhesive sustained-release vaginal tablet. This invention includes at least one probiotic strain of the genus, compressed with an excipient suitable for conferring upon the tablet the properties of vaginal wall mucoadhesion and sustained release. This innovative approach aims to improve the delivery and effectiveness of therapeutic agents in women's health.
Career Highlights
Throughout her career, Claudia has demonstrated a commitment to advancing pharmaceutical sciences. Her work at Nexbiome Therapeutics has positioned her as a key player in the development of novel therapeutic solutions. With her expertise, she has contributed to the creation of products that address critical health needs.
Collaborations
Claudia collaborates with notable professionals in her field, including Pierre Tchoreloff and Vincent Mazel. These partnerships enhance her research and development efforts, fostering innovation and progress in drug delivery systems.
Conclusion
Claudia Thoral's contributions to the field of mucoadhesive drug delivery systems exemplify her dedication to improving healthcare solutions. Her innovative patent and collaborative efforts highlight her role as a leading inventor in the pharmaceutical industry.